Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 323

1.

Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton's Jelly.

Walecka I, Gil-Kulik P, Krzyżanowski A, Czop M, Galkowski D, Karwat J, Chomik P, Świstowska M, Kwaśniewska A, Bogucka-Kocka A, Kocki J.

Med Sci Monit. 2017 Apr 19;23:1886-1895.

2.

CD105 expression in early erythroid precursors.

García-Vela JA, Martin Rubio I, Marquet J, Alvarez Juarez MA.

Am J Hematol. 2017 Apr 12. doi: 10.1002/ajh.24763. [Epub ahead of print] No abstract available.

PMID:
28403526
3.

Tissue Engineering Therapy for Atrophic Maxilla Using Minimally Manipulated CD90 and CD105 Bone Marrow Stem Cells: A Case Report.

Valdivia E, Mendoza-Azpur G, Pando J, Cornejo H, Carrasco A, Nevins M, Kim D.

Int J Periodontics Restorative Dent. 2017 May/Jun;37(3):355-361. doi: 10.11607/prd.3119.

PMID:
28402346
4.

Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst.

Jamshidi S, Zargaran M, Roshanaei G, Hadadi F, Dehghani Nazhvani A.

J Dent (Shiraz). 2017 Mar;18(1):43-46.

5.

De Novo Emergence of Mesenchymal Stem-Like CD105<sup>+</sup> Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma.

Nomura Y, Yamashita T, Oishi N, Nio K, Hayashi T, Yoshida M, Hayashi T, Hashiba T, Asahina Y, Okada H, Sunagozaka H, Takatori H, Honda M, Kaneko S.

Transl Oncol. 2017 Apr;10(2):184-189. doi: 10.1016/j.tranon.2017.01.005. Epub 2017 Feb 6.

6.

Functional significance of CD105-positive cells in papillary renal cell carcinoma.

Matak D, Brodaczewska KK, Szczylik C, Koch I, Myszczyszyn A, Lipiec M, Lewicki S, Szymanski L, Zdanowski R, Czarnecka AM.

BMC Cancer. 2017 Jan 5;17(1):21. doi: 10.1186/s12885-016-2985-7.

7.

Correlations between endothelial cell markers CD31, CD34 and CD105 in colorectal carcinoma.

Deliu IC, Neagoe CD, Beznă M, Genunche-Dumitrescu AV, Toma SC, Ungureanu BS, Uscatu CD, Beznă MC, Lungulescu CV, Pădureanu V, Gheonea DI, Ciurea T, ForŢofoiu M.

Rom J Morphol Embryol. 2016;57(3):1025-1030.

8.

[Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].

Su J, Ji XB, Xie JH, Li W.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Dec 7;51(12):929-936. doi: 10.3760/cma.j.issn.1673-0860.2016.12.010. Chinese.

PMID:
27978884
9.

Histopathological evaluation and expression of the pluripotent mesenchymal stem cell-like markers CD105 and CD44 in the synovial membrane of patients with primary versus secondary hip osteoarthritis.

Turdean SG, Jung I, Gurzu S, Zazgyva A, Fetyko A, Roman CO, Turcu M, Pop TS.

J Investig Med. 2017 Feb;65(2):363-369. doi: 10.1136/jim-2016-000244. Epub 2016 Nov 1.

PMID:
27803113
10.

Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice.

Czapla J, Matuszczak S, Wiśniewska E, Jarosz-Biej M, Smolarczyk R, Cichoń T, Głowala-Kosińska M, Śliwka J, Garbacz M, Szczypior M, Jaźwiec T, Langrzyk A, Zembala M, Szala S.

PLoS One. 2016 Jul 14;11(7):e0158745. doi: 10.1371/journal.pone.0158745. eCollection 2016.

11.

Correlations Between the Density of Tryptase Positive Mast Cells (DMCT) and that of New Blood Vessels (CD105+) in Patients with Gastric Cancer.

Micu GV, Stăniceanu F, Sticlaru LC, Popp CG, Bastian AE, Gramada E, Pop G, Mateescu RB, Rimbaş M, Archip B, Bleotu C.

Rom J Intern Med. 2016 Apr-Jun;54(2):113-20. doi: 10.1515/rjim-2016-0016.

PMID:
27352440
12.

Identification of a distinct subpopulation of fibroblasts from murine dermis: CD73(-) CD105(+) as potential marker of dermal fibroblasts subset with multipotency.

Lee SB, Shim S, Kim MJ, Shin HY, Jang WS, Lee SJ, Jin YW, Lee SS, Park S.

Cell Biol Int. 2016 Sep;40(9):1008-16. doi: 10.1002/cbin.10623. Epub 2016 Jul 11.

PMID:
27170595
13.

CD105 promotes chondrogenesis of synovium-derived mesenchymal stem cells through Smad2 signaling.

Fan W, Li J, Wang Y, Pan J, Li S, Zhu L, Guo C, Yan Z.

Biochem Biophys Res Commun. 2016 May 27;474(2):338-44. doi: 10.1016/j.bbrc.2016.04.101. Epub 2016 Apr 21.

PMID:
27107692
14.

Data from a comparative proteomic analysis of tumor-derived lung-cancer CD105(+) endothelial cells.

Jin H, Cheng X, Pei Y, Fu J, Lyu Z, Peng H, Yao Q, Jiang Y, Luo L, Zhuo H.

Data Brief. 2016 Mar 22;7:927-39. doi: 10.1016/j.dib.2016.03.062. eCollection 2016 Jun.

15.

Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.

Luo H, England CG, Shi S, Graves SA, Hernandez R, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W.

Clin Cancer Res. 2016 Aug 1;22(15):3821-30. doi: 10.1158/1078-0432.CCR-15-2054. Epub 2016 Mar 29.

PMID:
27026197
16.

CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.

Kong X, Wang Y, Liu S, Xing B, Yang Y, Li Y, Ren Z, Su C, Ma W, Wang R.

Mol Neurobiol. 2016 Jul;53(5):3503-3512. doi: 10.1007/s12035-015-9677-1. Epub 2016 Feb 16.

PMID:
26884265
17.

Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases.

Martinez LM, Labovsky V, Calcagno Mde L, Davies KM, Rivello HG, Wernicke A, Calvo JC, Chasseing NA.

Pathol Res Pract. 2016 Apr;212(4):350-5. doi: 10.1016/j.prp.2016.02.009. Epub 2016 Feb 2.

PMID:
26872535
18.

A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.

Miao Y, Zong M, Jiang T, Yuan X, Guan S, Wang Y, Zhou D.

Pituitary. 2016 Apr;19(2):194-201. doi: 10.1007/s11102-015-0698-6.

19.

Endoglin (CD105) coordinates the process of endometrial receptivity for embryo implantation.

Chadchan SB, Kumar V, Maurya VK, Soni UK, Jha RK.

Mol Cell Endocrinol. 2016 Apr 15;425:69-83. doi: 10.1016/j.mce.2016.01.014. Epub 2016 Jan 21.

PMID:
26802878
20.

Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects.

Dolinsek T, Sersa G, Prosen L, Bosnjak M, Stimac M, Razborsek U, Cemazar M.

Cancers (Basel). 2015 Dec 24;8(1). pii: E3. doi: 10.3390/cancers8010003.

Supplemental Content

Support Center